ISSCR News

ISSCR Guidelines Update Now Available in Chinese
The ISSCR is pleased to announce the availability of the Chinese language version of the ISSCR 2021 Guidelines for Stem Cell Research and Clinical Translation.

Member Spotlight: Haruhisa Inoue, MD, PhD
It is invaluable to be able to connect with colleagues from around the world who share common goals and objectives, and to have face-to-face, direct discussions with researchers of different generations.

ISSCR Journal Stem Cell Reports Named Official Conference Journal for BaCell 3D Conference
Stem Cell Reports, the premier open-access journal dedicated to advancing stem cell research, has been named the official conference journal for BaCell 3D, taking place from 23-25 June 2025, in Basel, Switzerland.

Stem Cell Transplant Clears Clinical Safety Hurdle for the Treatment of Wet Age-Related Macular Degeneration
Wet AMD in its early stages can be treated with drugs to reduce the formation of new blood vessels, but this treatment is inefficient in cases where blood vessel formation is already in its advanced stages. A new, alternative treatment for those patients may be surgical removal of the abnormal blood vessels followed by the transplantation of stem cell-derived retinal cells, according to a recent study led by Yong Liu and colleagues from Third Military Medical University Southwest Hospital, China, published in the journal Stem Cell Reports.

Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .